Sitagliptin phosphate monohydrate / metformin hydrochloride

Details

Files
Generic Name:
Sitagliptin phosphate monohydrate / metformin hydrochloride
Project Status:
Complete
Therapeutic Area:
Diabetes mellitus (Type 2)
Manufacturer:
Merck Frosst Canada Ltd.
Brand Name:
Janumet
Project Line:
Reimbursement Review
Project Number:
SR0182-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes mellitus (Type 2)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: